Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported outcome results of a randomised phase 3 trial

Ethan Basch, Karen Autio, Charles J. Ryan, Peter Mulders, Neal Shore, Thian Kheoh, Karim Fizazi, Christopher J. Logothetis, Dana Rathkopf, Matthew R. Smith, Paul N. Mainwaring, Yanni Hao, Thomas Griffin, Susan Li, Michael L. Meyers, Arturo Molina, Charles Cleeland

Research output: Contribution to journalArticlepeer-review

132 Scopus citations

Fingerprint

Dive into the research topics of 'Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported outcome results of a randomised phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences